One unexpected finding was that tumor initiation could be achieved in the absence of genomic alterations in the PI3K/AKT/mTOR signaling axis, given the extensive evidence implicating widespread mTOR activation in HNSC28,50–52. The gene discussed is MTOR; the disease is neoplasm.